Trends in advertising expenditure and potential exposure to ultra-processed food advertisements in South Africa between 2013 and 2022
Journal of Global Health Economics and Policy · 2026-10-21 · 6
DOI: 10.7189/001c.172401 ↗Abstract
Background Ultra-processed foods (UPFs) contribute substantially to unhealthy diets and the growing burden of obesity and diet-related non-communicable diseases (NCDs). Marketing of unhealthy food is an important influence of dietary behaviours and consumption patterns. This study examined advertising expenditure and exposure patterns for UPF advertisements in South Africa. Methods A quantitative descriptive study was conducted using secondary advertising monitoring data obtained from Nielsen South Africa between 2013 and 2022. Food and beverage products classified as ultra-processed according to the NOVA classification system were included. Advertising expenditure was aggregated by media type, food category, manufacturer, and broadcasting time. Broadcasting times were regrouped into daypart categories to assess exposure patterns. Descriptive analyses were conducted using Stata version 18 and Microsoft Excel. Results Total advertising expenditure of UPFs exceeded ZAR 13 billion. Carbonated beverages accounted for the largest share of beverage advertising expenditure (60.9%), while ready-to-eat cereals (14.5%), chocolate coated lines (14.0%), and chocolate slabs (13.3%) accounted for the highest food-related expenditures. Coca-Cola South Africa accounted for 61.1% of beverage advertising expenditure. Television was the dominant advertising platform, accounting for 69.2% of beverage and 92.2% of food-related advertising expenditure. Evening broadcasting periods accounted for the highest advertising expenditure for both beverage and food-related UPFs. Conclusions Substantial investment in UPF advertising occurred in South Africa, particularly through television advertising during peak evening viewing periods. The findings support stronger statutory regulation of unhealthy food advertising to reduce population exposure, particularly among children and adolescents.
EUVIMED